Hypoactive Sexual Desire Disorder (HSDD) Treatment Market 2019-2027 – Credence Research | Industry Size, Share & Forecast

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Is Expected To Expand At A CAGR of 5.2%

SAN JOSE, United States - August 14, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global hypoactive sexual desire disorder (HSDD) treatment market is set to expand at a CAGR of 5.2% from 2019 to 2027.

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

Market Insights

Hypoactive sexual desire disorder (HSDD) is currently on a rise in adult women population manifested by low self confidence and less connected with their partners. Recent approval of Vyleesi will provide essential momentum for the HSDD market growth. Currently 2 drugs such as BP101 and Prasterone 6.5 mg vaginal insert are under phase 3 clinical trial are being investigated for its safety and efficacy for treatment of HSDD.

Hypoactive sexual desire disorder is the most common type of sexual dysfunction occurring in adult women worldwide manifested by lack of sex interest for a period of six months or more due to personal distress or fluctuating sex hormones during the menstrual cycle. Accurate diagnosis of the symptoms manifested in hypoactive sexual desire disorder (HSDD) is very critical to finalize the treatment regimen which is either psychotherapy or pharmacotherapy. The PLISSIT model (Permission, Limited Information, Specific Suggestions and Intensive Therapy) aids in initial screening of HSDD. Psychotherapy is suggested to patients showing positive response to counseling sessions with sex therapist.

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

Pharmacotherapy comprises of buspirone and bupropion off label treatment for HSDD in women suffering with low libido associated with anxiety and depression. Testosterone transdermal patches are used as an off label treatment in premenopausal and postmenopausal women with HSDD. Flibanserin is currently the only drug approved by USFDA for treating HSDD in premenopausal women owing to its multifunctional serotonin agonist and antagonist pharmacodynamic profile.

North America is the largest regional segment in the hypoactive sexual desire disorder (HSDD) treatment market representing a market share of 38.5%. The chief attributing factors responsible for its supreme market growth are growing incidence of low libido in the female population owing to increasing stress in daily life and fluctuating sex hormones during the menstrual cycle. Domicile of key players such as AMAG Pharmaceutcials, Allergan, Plc., S1 Biopharma, Inc. and Sprout Pharmaceuticals, Inc. further propel the market growth in North America regional segment. Europe is placed in the second position with a market share of 32.4% primarily due to affordable reimbursement scenario for the medicines prescribed for the treatment of hypoactive sexual desire disorder (HSDD). Asia Pacific holding a market share of 15.2% will be growing at a rapid pace during the forecast period owing to rising prevalence of HSDD in working women population and developing healthcare infrastructure.

Pharmaceutical companies providing pharmacotherapy for treating hypoactive sexual desire disorder are AMAG Pharmaceutcials, Allergan, Plc., Ivix, LLX., EndoCeutics, Inc., Emotional Brain BV., S1 Biopharma, Inc. and Sprout Pharmaceutcials, Inc.

Key Market Movements:

Growing incidence of low sex drive in women population worldwide
Affordable reimbursement scenario for pharmacotherapy employed in the treatment of HSDD
Recent approval of Vyleesi and strong product pipeline will further propel the HSDD market growth during the forecast period

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

TOC:

1. Preface...

2. Executive Summary...

3. Hypoactive Sexual Desire Disorder Treatment Market: Dynamics and Future Outlook...

Chapter 4. Global Hypoactive Sexual Desire Disorder Treatment Market, by Therapy
4.1. Overview
4.2. Buspirone
4.3. Bupropion
4.4. Testosterone
4.5. Flibanserin
4.6. Bremelanotide
4.7. Cognitive Behavior Therapy
4.8. Pipeline Analysis
4.8.1. Phase III Drug
4.8.1.1. Prasterone 6.5 mg Vaginal Insert
4.8.1.2. BP101

Chapter 5. Global Hypoactive Sexual Desire Disorder Treatment Market, by Geography
5.1. Overview
5.2. North America Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.2.1. North America Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.2.2. North America Hypoactive Sexual Desire Disorder Treatment Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017– 2027
5.3.1. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.3.2. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.4.1. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific...

Chapter 6. Company Profiles
6.1. AMAG Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Allergan, Plc.
6.3. Ivix LLX
6.4. EndoCeutics, Inc.
6.5. Emotional Brain BV ...

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/hypoactive-sexual-desire-disorder-hsdd-treatment-market-2019-2027-credence-research-industry-size-share-forecast/88908175

Source: MarketersMedia

Release ID: 88908175

Other Sports News

Student shot at Texas high school; suspect still at large

Jan 23, 2020

BELLAIRE, Texas — A student was shot Tuesday at a high school in Texas and a suspect remained at large, local officials said. Emergency crews were seen performing CPR as the student was carried on a stretcher to an ambulance outside Bellaire High School, KPRC-TV reports. There were conflicting media reports about whether the shooting happened inside or outside the school. The city, a suburb south west of Houston, confirmed on Twitter that there was a shooting and said the suspect is still at large. It advised resident to avoid the area around the school or remain in their homes....

Oturu scores 30 as Minnesota beats No. 19 Michigan 75-67

Jan 23, 2020

MINNEAPOLIS — Daniel Oturu shook off an injury and had a career game to help Minnesota take down another ranked opponent. Oturu scored a career-high 30 points and the Gophers went on a late 11-0 run to beat No. 19 Michigan 75-67 on Sunday. The sophomore center had 20 points in a dominant first half, and he continued his roll with six quick points after the break. But with 14:35 remaining, he hit the deck hard while fighting for a rebound. He stayed on the floor for nearly five minutes, clutching his left shoulder as a hush fell over the...

Madrid beats Atlético in shootout, wins Spanish Super Cup

Jan 23, 2020

JEDDAH, Saudi Arabia — Real Madrid beat Atlético Madrid in a penalty shootout on Sunday to win the first edition of the new-look Spanish Super Cup that was held in Saudi Arabia despite criticism from human rights groups. Madrid won the shootout 4-1 after the final ended 0-0 after extra time. Dani Carvajal, Rodrygo, Luka Modric and Sergio Ramos all converted their spot kicks for Madrid. Atlético’s Saul Ñíguez missed his first penalty and Madrid goalkeeper Thibaut Courtois blocked the second attempt by Thomas Partey. Kieran Trippier converted for Atlético. “I had studied their penalty-takers before,” Courtois said. “I knew...

Bey scores 33, leads No. 16 Villanova past Georgetown 80-66

Jan 23, 2020

PHILADELPHIA — Saddiq Bey hit eight 3-pointers and scored a career-high 33 points to lead No. 16 Villanova to an 80-66 win over Georgetown on Saturday. Bey, a 6-foot-8 sophomore forward, hadn't been much of a 3-pointer shooter this season for the Wildcats (12-3, 3-1 Big East). He'd made only 21 and four of those came in a nonconference game against Ohio. He shot just 3-for-10 overall in a win this week at Creighton, hardly a sign he was about to bust out with a career game against the Hoyas (11-6, 1-3). Left open, and determined to shoot, Bey had...

Olympic champ David Gleirscher gets 1st World Cup luge win

Jan 23, 2020

ALTENBERG, Germany — Olympic champion David Gleirscher finally got his first World Cup luge victory, leading Austria’s sweep of gold Saturday. Gleirscher finished two runs at historic Altenberg in 1 minute, 48.150 seconds to hold off Italy’s Dominik Fischnaller by about one-quarter of a second. Fischnaller finished in 1:48.383 and Germany’s Felix Loch was third in 1:48.420. Gleirscher becomes the third different Austrian man to win a race this season. He’s 1 for 1 at the Olympics, after being the surprise winner of gold at the 2018 Pyeongchang Games. And he’s now 1 for 59 in World Cup races, getting...

Sukan360 is a proud Malaysian Sports website enthusiastic in our local players and bring Malaysian sports news first and foremost.

Soccer Racing Shootings Golf Sports Governance Men's Sports Women's Sports Press Releases